Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Genetics

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    April 2020
  1. KATONA BW, Clark DF, Domchek SM
    CDH1 on Multigene Panel Testing: Look Before You Leap.
    J Natl Cancer Inst. 2020;112:330-334.
    PubMed     Abstract available


    May 2019
  2. VOS JR, Fakkert IE, de Hullu JA, van Altena AM, et al
    Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
    J Natl Cancer Inst. 2019 May 11. pii: 5488012. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  3. XU Z, Sandler DP, Taylor JA
    Blood DNA methylation and breast cancer: A prospective case-cohort analysis in the Sister Study.
    J Natl Cancer Inst. 2019 Apr 15. pii: 5466458. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  4. NGUYEN B, Veys I, Leduc S, Bareche Y, et al
    Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer.
    J Natl Cancer Inst. 2019 Feb 21. pii: 5355042. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  5. SAINTIGNY P, William WN Jr, Foy JP, Papadimitrakopoulou V, et al
    Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
    J Natl Cancer Inst. 2018;110.
    PubMed     Abstract available


  6. HILLMAN RT, Chisholm GB, Lu KH, Futreal PA, et al
    Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
    J Natl Cancer Inst. 2018;110.
    PubMed     Abstract available


    October 2017
  7. LIU B, Mitani Y, Rao X, Zafereo M, et al
    Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
    J Natl Cancer Inst. 2017;109.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: